Esmat Ashour

750 total citations
28 papers, 579 citations indexed

About

Esmat Ashour is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Esmat Ashour has authored 28 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Esmat Ashour's work include Liver Disease Diagnosis and Treatment (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Parasites and Host Interactions (5 papers). Esmat Ashour is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Parasites and Host Interactions (5 papers). Esmat Ashour collaborates with scholars based in Egypt, United Kingdom and Saudi Arabia. Esmat Ashour's co-authors include Mohga S. Abdalla, Philip G. McTernan, Alison L. Harte, Sudhesh Kumar, Yehia Shaker, Gyanendra Tripathi, Kirsty McGee, Ashraf I. Amin, Hayat M. Sharada and S. J. Creely and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Nutritional Biochemistry and Parasitology.

In The Last Decade

Esmat Ashour

26 papers receiving 567 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Esmat Ashour 327 172 158 117 65 28 579
Merve Savaş 224 0.7× 91 0.5× 41 0.3× 85 0.7× 98 1.5× 46 771
Kiki Schraa 178 0.5× 333 1.9× 123 0.8× 50 0.4× 26 0.4× 20 678
Mounzer Soued 270 0.8× 201 1.2× 156 1.0× 95 0.8× 79 1.2× 12 720
Merav Strauss 157 0.5× 220 1.3× 138 0.9× 61 0.5× 20 0.3× 22 722
Shanshan Liu 226 0.7× 130 0.8× 33 0.2× 32 0.3× 24 0.4× 35 515
Marcel Sorribas 436 1.3× 439 2.6× 212 1.3× 106 0.9× 138 2.1× 5 835
Charlotte Mechler 361 1.1× 177 1.0× 198 1.3× 126 1.1× 37 0.6× 16 714
M Berrutti 160 0.5× 191 1.1× 111 0.7× 114 1.0× 85 1.3× 25 653
Denise Cerqueira Paranaguá‐Vezozzo 506 1.5× 65 0.4× 107 0.7× 171 1.5× 341 5.2× 42 825
Ahmet Cumhur Dülger 77 0.2× 88 0.5× 47 0.3× 47 0.4× 29 0.4× 68 494

Countries citing papers authored by Esmat Ashour

Since Specialization
Citations

This map shows the geographic impact of Esmat Ashour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esmat Ashour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esmat Ashour more than expected).

Fields of papers citing papers by Esmat Ashour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esmat Ashour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esmat Ashour. The network helps show where Esmat Ashour may publish in the future.

Co-authorship network of co-authors of Esmat Ashour

This figure shows the co-authorship network connecting the top 25 collaborators of Esmat Ashour. A scholar is included among the top collaborators of Esmat Ashour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esmat Ashour. Esmat Ashour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ashour, Esmat, et al.. (2022). Association of gene polymorphisms of ACE, AGT, and ARNT-like protein 1 with susceptibility to gestational diabetes. SHILAP Revista de lepidopterología. 23(1). 2 indexed citations
2.
Ashour, Esmat, et al.. (2022). Chia Seeds Oil Suppresses the Resistance of Hepatocellular CarcinomaCells to Liposomal-doxorubicin and Upregulates the Tumor SuppressormiRNAs. Current Pharmaceutical Biotechnology. 24(4). 570–578. 3 indexed citations
3.
Ashour, Esmat, et al.. (2020). Evaluation of genetic susceptibility of six type II diabetes Genome-Wide association tudies loci for obesity. Meta Gene. 26. 100758–100758. 3 indexed citations
4.
Dayem, Soha M. Abd El, et al.. (2018). Evaluation of pro-inflammatory and anti-inflammatory cytokines in type 1 diabetes mellitus. SHILAP Revista de lepidopterología. 42(1). 27 indexed citations
5.
Borai, Ibrahim H., et al.. (2018). Association of nonalcoholic fatty liver disease grades with the plasma cell antigen-1 (PC-1) gene polymorphism. Egyptian Journal of Medical Human Genetics. 19(3). 241–246. 2 indexed citations
6.
Ashour, Esmat, et al.. (2017). MTP genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patients. Genes & Diseases. 4(4). 222–228. 12 indexed citations
7.
Borai, Ibrahim H., et al.. (2017). Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 5(2). 109–118. 15 indexed citations
8.
Badawy, M.M., et al.. (2017). Serotypes of Streptococcus pneumoniae in Egyptian children: are they covered by pneumococcal conjugate vaccines?. European Journal of Clinical Microbiology & Infectious Diseases. 36(12). 2385–2389. 6 indexed citations
9.
Borai, Ibrahim H., et al.. (2017). Genetic Variants of Interleukin-18 Promoter Gene in Coronary Artery Disease. Egyptian Journal of Chemistry. 60(5). 3–4. 1 indexed citations
10.
Shaker, Yehia, et al.. (2014). Hepatobiliary Schistosomiasis. Journal of Clinical and Translational Hepatology. 2(3). 212–6. 38 indexed citations
11.
Shaker, Yehia, et al.. (2014). Serum and urinary transforming growth factor beta 1 as biochemical markers in diabetic nephropathy patients. Beni-Suef University Journal of Basic and Applied Sciences. 3(1). 16–23. 20 indexed citations
12.
Zahran, Faten, et al.. (2013). Interleukin-4 and interleukin-4 receptor alpha polymorphisms in atopic dermatitis: A case-control study. 7(3). 1 indexed citations
13.
McGee, Kirsty, Gyanendra Tripathi, Nasser M. Al‐Daghri, et al.. (2011). Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro. The Journal of Nutritional Biochemistry. 23(1). 39–50. 53 indexed citations
14.
Shaker, Yehia, et al.. (2011). Effect of host portal and peripheral sera fractions on cell proliferation of Schistosoma mansoni schistosomules.. PubMed. 28(3). 630–7. 2 indexed citations
15.
Draz, Hossam M., et al.. (2010). Effects of Peg-Interferon-Alpha-2A on Schistosoma mansoni Infection in Mice. Journal of Parasitology. 96(4). 703–708. 4 indexed citations
16.
Harte, Alison L., Nancy F. da Silva, S. J. Creely, et al.. (2010). Elevated endotoxin levels in non-alcoholic fatty liver disease. Journal of Inflammation. 7(1). 15–15. 316 indexed citations
17.
Abdalla, Mohga S., et al.. (2010). Association of serum Leptin and Adiponectin with Atherosclerosis in obese and non-obese Type 2 Diabetes Mellitus patients. 1 indexed citations
18.
Zahran, Faten, et al.. (2010). Interleukin 10 receptor alpha subunit (IL-10RA) gene polymorphism and IL-10 serum levels in Egyptian atopic patients.. PubMed. 20(1). 20–6. 21 indexed citations
19.
Draz, Hossam M., Esmat Ashour, Yehia Shaker, et al.. (2008). Host Susceptibility to Schistosomes: Effect of Host Sera on Cell Proliferation of Schistosoma mansoni Schistosomula. Journal of Parasitology. 94(6). 1249–1252. 4 indexed citations
20.
Shaker, Yehia, Catherine H. Wu, Esmat Ashour, et al.. (1998). Human portal serum stimulates cell proliferation in immature Schistosoma mansoni. Parasitology. 117(4). 293–299. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026